Eli Lilly and Company (LLY)
204.21 +0.39 (0.19%)
Pre-market: 5:12AM EST
| Previous close | 204.52 |
| Open | 203.57 |
| Bid | 199.63 x 1000 |
| Ask | 206.32 x 1000 |
| Day's range | 201.75 - 205.55 |
| 52-week range | 117.06 - 218.00 |
| Volume | 2,132,729 |
| Avg. volume | 4,329,243 |
| Market cap | 195.346B |
| Beta (5Y monthly) | 0.28 |
| PE ratio (TTM) | 30.02 |
| EPS (TTM) | 6.79 |
| Earnings date | 27 Apr 2021 |
| Forward dividend & yield | 3.40 (1.67%) |
| Ex-dividend date | 11 Feb 2021 |
| 1y target est | 216.14 |
- PR Newswire
Welldoc and Lilly collaborate to integrate BlueStar® app capabilities into Lilly's connected insulin solutions
Welldoc, Inc., and Eli Lilly and Company (NYSE: LLY) announced today a collaboration and licensing agreement to integrate Welldoc's software into Lilly's connected insulin solutions, currently in development. Under the terms of the agreement, Lilly and Welldoc will collaborate to create a new version of the BlueStar® insulin management solution that integrates insulin dosing data for several Lilly insulins. Lilly will commercialize the pen platform, which will include the new app and Lilly's connected insulin pen solutions.
- PR Newswire
Lilly to Participate in Cowen Health Care Conference
Eli Lilly and Company (NYSE: LLY) will participate in the Cowen and Company 41st Annual Health Care Conference on Thursday, March 4, 2021. Daniel Skovronsky, M.D., Ph.D., Lilly's Chief Scientific Officer and President of Lilly Research Laboratories, will participate in a fireside chat at 9:10 a.m., Eastern Time.
- Motley Fool
3 Reasons Rigel Pharmaceuticals Stock Can Continue Soaring
Shares of Rigel Pharmaceuticals (NASDAQ: RIGL) recently popped after the company announced a collaboration deal with one of America's largest drugmakers, Eli Lilly (NYSE: LLY). A new collaboration deal with a big pharmaceutical company isn't the only reason to keep an eye on this often overlooked biotech stock. Here's why investors can look forward to outstanding returns from Rigel Pharmaceuticals in the years to come.
